Singapore’s Eu Yan Sang to be acquired by Mitsui, Rohto Pharmaceutical for US$594 million

Singapore's Eu Yan Sang to be acquired by Mitsui, Rohto Pharmaceutical for US$594 million

Founded in 1879, Eu Yan Sang operates over 170 retail shops and 30 centers in Singapore, Hong Kong and Malaysia, according to Mitsui’s speech.

In 2016, Righteous Crane Holding privatized the business from the Singaporean stock market. At the time of the transaction, Eu Yan Sang was valued at around US$ 96 million.

In November 2022, Mitsui reported making an indirect investment in Eu Yan Sang. The Japanese business added that it had helped the growth of Eu Yan Sang’s ( EYS) business by promoting the brand and supporting international expansion.

Mitsui said,” Through these activities, Mitsui reconfirmed EYS’s solid business potential and how Mitsui may lead to its business development,” and that this resulted in the company’s decision to re-invest in Eu Yan Sang with Rohto and the establishment home via the specific purpose company.

The deal is expected to near by June, according to Tower Capital Asia’s speech.

According to the speech, WongPartnership serves as Eu Yan Sang’s financial advisor, while Deutsche Bank and UBS serve as their counterparts.